Form Type: 4

SEC EDGAR Link
Accession Number:0000905718-20-000724
Date:2020-06-26
Issuer: SOLENO THERAPEUTICS INC (SLNO)
Original Submission Date:

Reporting Person:

SINCLAIR ANDREW
C/O SOLENO THERAPEUTICS INC.
1235 RADIO ROAD, SUITE 110 CAMBRIDGE, MA 02139

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-06-26 P 3,333,330 a $1.65 10,302,602 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 shares are held by abingworth bioventures vii, lp ("abv vii"). abingworth llp is the investment manager of abv vii and has been delegated with all investment and dispositive power over the securities held by abv vii. reporting person is a partner and portfolio manager of abingworth llp,
f2 an investment committee approves investment and voting decisions by a majority vote, and no individual member has the sole control or voting power over the shares held by abv vii. from time to time, the investment committee may delegate investment and voting authority over certain securities held by abv vii to employees of abingworth subject to the supervision and oversight of the investment committee, including any limits on such authority imposed by the investment committee in its discretion and the right of the investment committee to revoke such authority at any time. the reporting person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, if any.
WhaleWisdom Logo

Elevate your investments